Aptose Biosciences Inc. (APTO)
NASDAQ: APTO · IEX Real-Time Price · USD
0.743
-0.004 (-0.52%)
At close: Jul 2, 2024, 3:53 PM
0.760
+0.017 (2.29%)
After-hours: Jul 2, 2024, 5:32 PM EDT
Aptose Biosciences Stock Forecast
APTO's stock price has decreased by -83.78% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 6 analysts with 12-month price forecasts for Aptose Biosciences stock have an average target of 14.83, with a low estimate of 5.00 and a high estimate of 38. The average target predicts an increase of 1,895.96% from the current stock price of 0.74.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for APTO stock from 6 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 1 | 1 | 2 | 2 |
| Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 5 | 5 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $7 | Strong Buy | Reiterates | $7 | +842.13% | Jun 14, 2024 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $15 → $6 | Strong Buy | Maintains | $15 → $6 | +707.54% | May 16, 2024 |
| Piper Sandler | Piper Sandler | Buy Maintains $5 | Buy | Maintains | $5 | +572.95% | Apr 3, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $23 | Strong Buy | Maintains | $23 | +2,995.56% | Mar 27, 2024 |
| Piper Sandler | Piper Sandler | Buy Maintains $12 → $5 | Buy | Maintains | $12 → $5 | +572.95% | Feb 1, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-3.17
from -7.58
EPS Next Year
-1.72
from -3.17
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | n/a | n/a | n/a |
| Avg | n/a | n/a | n/a |
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -1.98 | -1.24 | -1.84 |
| Avg | -3.17 | -1.72 | -1.79 |
| Low | -4.23 | -2.15 | -1.71 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.